(Bold for FDA approved)
How Xolybex works• Blocks dopamine 2 receptors, reducing positive symptoms of psychosis
• With injection, psychotic symptoms can improve within a few days, but it may take 1–2 weeks for notable improvement
• With oral formulation, psychotic symptoms can improve within 1 week, but it may take several weeks for full effect on behavior
Notable Side Effects• Neuroleptic-induced deficit syndrome
• Drug-induced parkinsonism
• Insomnia, restlessness, agitation, sedation
• Tardive dyskinesia (risk increases with duration of treatment and with dose)
• Risk of potentially irreversible involuntary dyskinetic movements may increase with cumulative dose and treatment duration
• Galactorrhea, amenorrhea
• Tachycardia
• Weight gain
• Hypomania
• Rare eosinophilia
Life Threatening Side Effects• Rare neuroleptic malignant syndrome may cause hyperpyrexia, muscle rigidity, delirium, and autonomic instability with elevated creatine phosphokinase, myoglobinuria (rhabdomyolysis), and acute renal failure
• Rare seizures
• Rare jaundice, leukopenia
• As a class, antipsychotics are associated with an increased risk of death and cerebrovascular events in elderly patients with dementia; not approved for treatment of dementia-related psychosis

common

not usual
• Wait
• Wait
• Wait
• For drug-induced parkinsonism, add an anticholinergic agent
• Beta blockers, benzodiazepines, or serotonin 2A antagonists (e.g., mirtazapine, cyproheptadine) may reduce akathisia
• Reduce the dose
• For sedation, give at night
• Switch to an atypical antipsychotic
• Weight loss, exercise programs, and medical management for high BMIs, diabetes, dyslipidemia
• Metformin may help prevent or reverse antipsychotic-induced weight gain
• Oral 3–6 mg/day in divided doses
• Intramuscular 40–120 mg every 1–4 weeks
Dosage Forms• Tablet 0.5 mg, 3 mg
• Injection 20 mg/mL, 100 mg/mL
• Should periodically reevaluate long-term usefulness in individual patients, but treatment may need to continue for many years
• No
Renal Impairment• Oral: recommended to take half or less of usual adult dose
• Intramuscular: recommended dose schedule generally 10–20 mg every 15 days
Hepatic Impairment• Use with caution
• Oral: recommended to take half or less of usual adult dose
Cardiac Impairment• Use with caution
• Oral: recommended to take half or less of usual adult dose
Elderly• Intramuscular: recommended initial dose generally 5 mg; recommended dose schedule generally 10–20 mg every 15 days
• Oral: recommended to take half or less of usual adult dose
• Although conventional antipsychotics are commonly used for behavioral disturbances in dementia, no agent has been approved for treatment of elderly patients with behavioral symptoms of dementia such as agitation
• Elderly patients with dementia-related psychosis treated with antipsychotics are at increased risk of death compared to placebo, and also have an increased risk of cerebrovascular events
Children and Adolescents• Not recommended for use in children
Pregnancy• Not recommended for use during pregnancy
• There is a risk of abnormal muscle movements and withdrawal symptoms in newborns whose mothers took an antipsychotic during the third trimester; symptoms may include agitation, abnormally increased or decreased muscle tone, tremor, sleepiness, severe difficulty breathing, and difficulty feeding
• Reports of drug-induced parkinsonism, jaundice, hyperreflexia, hyporeflexia in infants whose mothers took a conventional antipsychotic during pregnancy
• Psychotic symptoms may worsen during pregnancy and some form of treatment may be necessary
• Atypical antipsychotics may be preferable to conventional antipsychotics or anticonvulsant mood stabilizers if treatment is required during pregnancy
Breast Feeding• Some drug is found in mother’s breast milk
• Recommended either to discontinue drug or bottle feed
Based on data Published online by Cambridge University Press
Compiled by Dr. Jash Ajmera